Publications:3
- Home
- Profiles
Paul Endres, MD
- About Me
- Locations
- Publications
- Industry Relationships
About Me
Language
Position
About Me
Language
Position
Locations
Publications
Selected Publications
- Crohn's disease: Failure of a proprietary fluorescent in situ hybridization assay to detect M. avium subspecies paratuberculosis in archived frozen intestine from patients with Crohn's disease.. Robert J. Greenstein, Liya Su, Peter S. Fam, Brooke Gurland, Paul Endres, Sheldon T. Brown. BMC Research Notes
- Urothelial metaplasia of the seminal vesicles: A report of 2 cases. Sofia Kazi, Paul J.H. Endres, Pamela D. Unger, Guang Qian Xiao. Annals of Diagnostic Pathology
- Pancreatoblastoma: A rare tumor still evolving in clinical presentation and histology. Chitra Balasundaram, Munish Luthra, Disaya Chavalidthamrong, Jonathan Chow, Hina Khan, Paul J.H. Endres. Journal of the Pancreas
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Endres during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Cetrulo Law Firm
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.